SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001437749-24-018972 from Cyclo Therapeutics, Inc. (CYTH, CYTHW) (CIK 0000922247)

Cyclo Therapeutics, Inc. (CYTH, CYTHW) (CIK 0000922247)
Date: June 3, 2024 · CIK: 0000922247 · Accession: 0001437749-24-018972

AI Filing Summary & Sentiment

File numbers found in text: 333-279703

Date
June 3, 2024
Author
/s/ N. Scott Fine
Form
CORRESP
Company
Cyclo Therapeutics, Inc. (CYTH, CYTHW) (CIK 0000922247)

Letter

ctdh20240531_corresp.htm

6714 NW 16th Street, Suite B

Gainesville, FL 32653

June 3, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, NE

Washington, DC 20549

Attention: Doris Stacey Gama

Re:

Cyclo Therapeutics, Inc.

Registration Statement on Form S-3

Filed May 24, 2024

File No. 333-279703

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cyclo Therapeutics, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 5:00 p.m., Eastern Time, on June 4, 2024, or as soon thereafter as is practicable.

The Company requests that it be notified of such effectiveness by a telephone call to Sarah Hewitt of Fox Rothschild LLP at (212) 878-1435.

Thank you for your assistance in this matter. Should you have any questions, please call Ms. Hewitt.

Very truly yours,
/s/ N. Scott Fine

Show Raw Text
CORRESP
1
filename1.htm

	ctdh20240531_corresp.htm

6714 NW 16th Street, Suite B

Gainesville, FL 32653

June 3, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, NE

Washington, DC 20549

Attention: Doris Stacey Gama

			Re:

			Cyclo Therapeutics, Inc.

			Registration Statement on Form S-3

			Filed May 24, 2024

			File No. 333-279703

			Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cyclo Therapeutics, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 5:00 p.m., Eastern Time, on June 4, 2024, or as soon thereafter as is practicable.

The Company requests that it be notified of such effectiveness by a telephone call to Sarah Hewitt of Fox Rothschild LLP at (212) 878-1435.

Thank you for your assistance in this matter. Should you have any questions, please call Ms. Hewitt.

			Very truly yours,

			/s/ N. Scott Fine

			N. Scott Fine

			Chief Executive Officer

cc:         Sarah Hewitt, Esq.